UNSPSC 51434960: Amlodipine/Indapamide/Perindopril arginine

Perindopril/indapamide/amlodipine is a triple-drug therapy incorporating an ACE inhibitor for the treatment of hypertension.

UNSPSC 51434960 Amlodipine/Indapamide/Perindopril arginine is a Commodity code that specifies a fixed-dose combination antihypertensive pharmaceutical product. State and local procurement activity under this code shows no recent relevant solicitations; the most recent opportunities tagged to this code involve unrelated purchases (medical oxygen cylinder rental, forensic drug standards, naloxone, BLS/ALS pharmaceuticals, and peer support services) that do not match the scope of this specific pharmaceutical combination. The code represents a narrow, single-product line rather than a category open to multiple vendors or formulations, which explains the sparse activity in state and local markets where bulk purchasing of this particular branded or generic combination remains limited relative to broader cardiovascular pharmaceutical categories.

State and local governments do not appear to be actively soliciting this specific three-drug combination through formal RFPs, RFQs, IFBs, or ITBs at present. Procurement under this code, when it occurs, would typically flow through established pharmaceutical contracts managed by state health departments, counties with health programs, or school districts with employee health plans rather than through standalone solicitations. No geographic concentration, issuing-body pattern, or representative recent opportunity is evident from available records, indicating either institutional consolidation of antihypertensive purchases under broader therapeutic-class agreements or limited adoption of this particular fixed-dose combination in state and local formularies. Business development professionals should monitor cooperative purchasing vehicles and state health department framework agreements for this commodity rather than expect standalone market activity.